Viewing Study NCT01421004


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-02-02 @ 11:25 PM
Study NCT ID: NCT01421004
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2011-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Excluding Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None tumors View
None phase I View
None crossover View
None bioequivalence View